Editorial Commentary
Is adagrasib just another sotorasib?—or, should we differentiate their usage according to patients’ clinical presentation?
Translational Lung Cancer Research
2023;
12
(5)
:940-943
.
(31 May 2023)
Dynamic change of CD8+ T cell: immunotherapy fate tell?
Translational Lung Cancer Research
2023;
12
(5)
:944-947
.
(31 May 2023)
Taking it up a notch: a promising immunotherapy against small cell lung cancer
Translational Lung Cancer Research
2023;
12
(5)
:948-952
.
(31 May 2023)
Towards a clinically applicable histomolecular classification of lung adenocarcinomas?
Translational Lung Cancer Research
2023;
12
(5)
:953-956
.
(31 May 2023)
Top-of-the-art cytometry as a novel tool to aid in lung cancer immunotherapy
Translational Lung Cancer Research
2023;
12
(5)
:957-961
.
(31 May 2023)
Original Article
Trends in women’s representation as lead authors in high impact journals of lung cancer
Translational Lung Cancer Research
2023;
12
(5)
:962-970
.
(31 May 2023)
Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer
Translational Lung Cancer Research
2023;
12
(5)
:971-984
.
(31 May 2023)
Genomic alterations dissection revealed MUC4 mutation as a potential driver in lung adenocarcinoma local recurrence
Translational Lung Cancer Research
2023;
12
(5)
:985-998
.
(31 May 2023)
The radioprotectant nano-genistein enhances radiotherapy efficacy of lung tumors in mice
Translational Lung Cancer Research
2023;
12
(5)
:999-1010
.
(31 May 2023)
BRCA mutations detected by tumour next-generation sequencing in non-small cell lung cancer: impact on response to therapy and disease course
Translational Lung Cancer Research
2023;
12
(5)
:1011-1022
.
(31 May 2023)
Radiomic biomarkers from chest computed tomography are assistive in immunotherapy response prediction for non-small cell lung cancer
Translational Lung Cancer Research
2023;
12
(5)
:1023-1033
.
(31 May 2023)
Clinical and prognostic significance of detecting CEA, EGFR, LunX, c-met and EpCAM mRNA-positive cells in the peripheral blood, tumor-draining blood and bone marrow of non-small cell lung cancer patients
Translational Lung Cancer Research
2023;
12
(5)
:1034-1050
.
(31 May 2023)
Inhibition of BPHL inhibits proliferation in lung carcinoma cell lines
Translational Lung Cancer Research
2023;
12
(5)
:1051-1061
.
(31 May 2023)
Harmine loaded Au@MSNs@PEG@Asp6 nano-composites for treatment of spinal metastasis from lung adenocarcinoma by targeting ANXA9 in vivo experiment
Translational Lung Cancer Research
2023;
12
(5)
:1062-1077
.
(31 May 2023)
Effects of a ground-glass opacity component on the recurrence and survival of pathological stage IA3 lung adenocarcinoma: a multi-institutional retrospective study
Translational Lung Cancer Research
2023;
12
(5)
:1078-1092
.
(31 May 2023)
Targeting complement C5a to improve radiotherapy sensitivity in non-small cell lung cancer
Translational Lung Cancer Research
2023;
12
(5)
:1093-1107
.
(31 May 2023)
Comparative efficacy and safety of multitarget angiogenesis inhibitor combined with immune checkpoint inhibitor and nivolumab monotherapy as second-line or beyond for advanced lung adenocarcinoma in driver-negative patients: a retrospective comparative cohort study
Translational Lung Cancer Research
2023;
12
(5)
:1108-1121
.
(31 May 2023)
Assessing how lung cancer screening guidelines contribute to racial disparities in screening access
Translational Lung Cancer Research
2023;
12
(5)
:1122-1132
.
(31 May 2023)
Mini-Review
Tumor-associated prognostic factors extractable from chest CT scans in patients with lung cancer
Translational Lung Cancer Research
2023;
12
(5)
:1133-1139
.
(31 May 2023)
